Dr. David Welch
Chief Scientific Officer and Co-Founder Synthesis Capital, Frederick, MD, USA
Ph.D. Plant developmental cell biology, Utrecht University, Utrecht The Netherlands
B.Sc. Biology, University of California at Berkeley, CA, USA
Dr. Welch is the Chief Scientific Officer and Co-Founder at Synthesis Capital, a new investment manager created to transform our food system through food technology. At Synthesis, David combines his background in plant biology, cell therapy, and alternative protein technology to identify exceptional technology-focused start-ups, lead on all scientific and technical due diligence processes, and support Synthesis portfolio companies with their technical and scale-up challenges.
Prior to joining Synthesis Capital, David was Director of Science and Technology at The Good Food Institute where he helped start-ups, investors, corporations, and universities accelerate the development, scale-up, and commercialization of alternative protein technology. He previously served in roles of increasing responsibility within the life science industry at Thermo Fisher Scientific, Qiagen, Meso Scale Discovery, and 3M Healthcare, which included the product development and commercialization of cells, scaffolds, cell engineering tools, and cell culture media for cell therapy and bioprocessing applications.